Drug shortage
Telmisartan Tablet · Boehringer Ingelheim Pharmaceuticals, Inc.
FDA drug shortage · To Be Discontinued · updated Oct 22, 2024
Key facts
| Generic name | Telmisartan Tablet |
|---|---|
| Company | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Presentation | Micardis, Tablet, 20 mg (NDC 0597-0039-37) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 0597-0039-37 |
| First posted | Oct 22, 2024 |
| Last updated | Oct 22, 2024 |
| Discontinued | Oct 22, 2024 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: